Towards in silico prediction of immunogenic epitopes

Trends in Immunology

Volumn 24, Issue 12, 2003, Pages 667-674

  Flower, Darren R ^a  

^a EDWARD JENNER INST FOR VACC RES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTIFICIAL INTELLIGENCE; BIOINFORMATICS; COMPUTER MODEL; COMPUTER PREDICTION; GENOMICS; IMMUNE SYSTEM; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DYNAMICS; MOLECULAR MODEL; PROTEIN STRUCTURE; REVIEW;

EID: 0344309217     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2003.10.006     Document Type: Review

References (65)

1. Alix A.J. Predictive estimation of protein linear epitopes by using the program PEOPLE. Vaccine. 18:1999;311-314.
2. Thornton J.M., , et al. Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J. 5:1986;409-413.
3. Flower D.R., , et al. Computational Vaccine Design. Flower D.R. Drug Design, Cutting Edge Approaches. 2002;136-180 RSC publications, London.
4. Deavin A.J., , et al. Statistical comparison of established T-cell epitope predictors against a large database of human and murine antigens. Mol. Immunol. 33:1996;145-155.
5. Nussbaum A.K., , et al. Using the world wide web for predicting CTL epitopes. Curr. Opin. Immunol. 15:2003;69-74.
6. Brusic V., , et al. A neural network model approach to the study of human TAP transporter. Silico Biol. 1:1999;109-121.
7. Holzhutter H.G., , et al. A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome. J. Mol. Biol. 286:1999;1251-1265.
8. Holzhutter H.G., Kloetzel P.M. A kinetic model of vertebrate 20S proteasome accounting for the generation of major proteolytic fragments from oligomeric peptide substrates. Biophys. J. 79:2000;1196-1205.
9. Nussbaum A.K., , et al. PAProC: a prediction algorithm for proteasomal cleavages available on the WWW. Immunogenetics. 53:2001;87-94.
10. Kesmir C., , et al. Prediction of proteasome cleavage motifs by neural networks. Protein Eng. 15:2002;287-296.
11. Altuvia Y., Margalit H. Sequence signals for generation of antigenic peptides by the proteasome: implications for proteasomal cleavage mechanism. J. Mol. Biol. 295:2000;879-890.
12. Housset D., Malissen B. What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity? Trends Immunol. 24:2003;429-437.
13. Sette A., , et al. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc. Natl. Acad. Sci. U. S. A. 86:1989;3296-3300.
14. De Groot A.S., , et al. Immuno-informatics: Mining genomes for vaccine components. Immunol. Cell Biol. 80:2002;255-269.
15. Bian H., , et al. The use of bioinformatics for identifying class II-restricted T-cell epitopes. Methods. 29:2003;299-309.
16. Schonbach C., , et al. Large-scale computational identification of HIV T-cell epitopes. Immunol. Cell Biol. 80:2002;300-306.
17. Nielsen M., , et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 12:2003;1007-1017.
18. Udaka K., , et al. Empirical evaluation of a dynamic experiment design method for prediction of MHC class I-binding peptides. J. Immunol. 169:2002;5744-5753.
19. Donnes P., Elofsson A. Prediction of MHC class I binding peptides, using SVMHC. BMC Bioinformatics. 3:2002;25-30.
20. Reche P., , et al. Prediction of MHC class I binding peptides using profile motifs. Hum. Immunol. 63:2002;701-708.
21. Doytchinova I.A., , et al. Additive method for the prediction of protein-peptide binding affinity. application to the MHC class I molecule HLA-A*0201. J. Proteome Res. 1:2002;263-272.
22. Doytchinova, I.A. and Flower, D.R. Towards the in silico identification of class II restricted T-cell epitopes: a partial least squares iterative self-consistent algorithm for affinity prediction of peptides binding to MHC class II molecule DRB1*0401. Bioinformatics (in press).
23. Guan P., , et al. HLA-A3 supermotif defined by quantitative structure-activity relationship analysis. Protein Eng. 16:2003;11-18.
24. Doytchinova I.A., Flower D.R. The HLA-A2 supermotif: A QSAR definition. Org. Biomol. Chem. 1:2003;2648-2654.
25. Yu K., , et al. Methods for prediction of peptide binding to MHC molecules: a comparative study. Mol. Med. 8:2002;137-148.
26. Blythe M.J., , et al. JenPep, a database of quantitative functional peptide data for immunology. Bioinformatics. 18:2002;434-439.
27. McSparron H., , et al. JenPep: a novel computational information resource for immunobiology and vaccinology. J. Chem. Inf. Comput. Sci. 43:2003;1276-1287.
28. Doytchinova I.A., Flower D.R. Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study. Proteins. 48:2002;505-518.
29. Doytchinova I.A., Flower D.R. A comparative molecular similarity index analysis (CoMSIA), study identifies an HLA-A2 binding supermotif. J. Comput. Aided Mol. Des. 16:2002;535-544.
30. Guan P., , et al. A comparative molecular similarity indices (CoMSIA), study of peptide binding to the HLA-A3 superfamily. Bioorg. Med. Chem. 11:2003;2307-2311.
31. Sturniolo T., , et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17:1999;555-561.
32. Zhang C., , et al. Structural principles that govern the peptide-binding motifs of class I MHC molecules. J. Mol. Biol. 281:1998;929-947.
33. Chelvanayagam G. A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics. 45:1996;15-26.
34. Chelvanayagam G. A roadmap for HLA-DR peptide binding specificities. Hum. Immunol. 58:1997;61-69.
35. Rognan D., , et al. Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. J. Med. Chem. 42:1999;4650-4658.
36. Schueler-Furman O., , et al. Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles. Protein Sci. 9:2000;1838-1846.
37. Logean A., , et al. Customized versus universal scoring functions: application to class I MHC-peptide binding free energy predictions. Bioorg. Med. Chem. Lett. 11:2001;675-679.
38. Logean A., Rognan D. Recovery of known T-cell epitopes by computational scanning of a viral genome. J. Comput. Aided Mol. Des. 16:2002;229-243.
39. Vasmatzis G., , et al. Computational determination of side chain specificity for pockets in class I MHC molecules. Mol. Immunol. 33:1996;1231-1239.
40. Rognan D., , et al. Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T-cell epitopes. Biochemistry. 33:1994;11476-11485.
41. Krebs S., , et al. Long-range effects in protein-ligand interactions mediate peptide specificity in the human major histocompatibilty antigen HLA-B27 (B*2701). Protein Sci. 8:1999;1393-1399.
42. Flower, D.R., et al. Computational vaccinology: quantitative approaches. Bioinformatic Strategies for Better Understanding of Immune Function. Novartis Found. Symp., 254 (October 2003), Wiley & Sons (in press).
43. Rammensee H., , et al. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 50:1999;213-219.
44. Doytchinova I.A., Flower D.R. Quantitative approaches to computational vaccinology. Immunol. Cell Biol. 80:2002;270-279.
45. Lu J., Celis E. Use of two predictive algorithms of the World Wide Web for the identification of tumor-reactive T-cell epitopes. Cancer Res. 60:2000;5223-5227.
46. Andersen M.H., , et al. Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens. 55:2000;519-531.
47. Seifert U., , et al. An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat. Immunol. 4:2003;375-379.
48. Saveanu L., , et al. Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases. Mol. Immunol. 39:2002;203-215.
49. Kim S.I., , et al. Regulation of cell surface major histocompatibility complex class I expression by the endopeptidase EP3.4.24.15 (thimet oligopeptidase). Biochem. J. 375:2003;111-120.
50. Grandea III A.G., Van Kaer L. Tapasin: an ER chaperone that controls MHC class I assembly with peptide. Trends Immunol. 22:2001;194-199.
51. Serwold T., , et al. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature. 419:2002;480-483.
52. Lu J., , et al. TAP-independent presentation of CTL epitopes by Trojan antigens. J. Immunol. 166:2001;7063-7071.
53. Tanioka T., , et al. Human leukocyte-derived arginine aminopeptidase. The third member of the oxytocinase subfamily of aminopeptidases. J. Biol. Chem. 278:2003;32275-32283.
54. Levy F., , et al. The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases. J. Immunol. 169:2002;4161-4171.
55. Parker K.C., , et al. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:1994;163-170.
56. Guan P., , et al. MHCPred: a server for quantitative prediction of peptide-MHC binding. Nucleic Acids Res. 31:2003;3621-3624.
57. Swain, M.T., et al. (2001) An automated approach to modelling class II MHC alleles and predicting peptide binding. 2nd Annual IEEE International Symposium On Bioinformatics And Bioengineering, Proceedings 81-88, IEEE Computer Soc., Los Alamitos.
58. Touloukian C.E., , et al. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice. J. Immunol. 164:2000;3535-3542.
59. Singh H., Raghava G.P. ProPred, prediction of HLA-DR binding sites. Bioinformatics. 17:2001;1236-1237.
60. Brusic V., , et al. MHCPEP, a database of MHC-binding peptides: update 1997. Nucleic Acids Res. 26:1998;368-371.
61. Schonbach C., , et al. FIMM, a database of functional molecular immunology: update 2002. Nucleic Acids Res. 30:2002;226-229.
62. Korber, B.T.M., et al. (2001). HIV Molecular Immunology, Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos.
63. Bhasin M., , et al. MHCBN: a comprehensive database of MHC binding and non-binding peptides. Bioinformatics. 19:2003;665-666.
64. Chen X., , et al. The binding database: data management and interface design. Bioinformatics. 18:2002;130-139.
65. Sathiamurthy M., , et al. Population of the HLA ligand database. Tissue Antigens. 61:2003;12-19.